Annual ROE
-228.43%
-81.68%-55.66%
December 31, 2023
Summary
- As of February 8, 2025, ALRN annual return on equity is -228.43%, with the most recent change of -81.68% (-55.66%) on December 31, 2023.
- During the last 3 years, ALRN annual ROE has fallen by -54.47% (-31.31%).
- ALRN annual ROE is now -1509.19% below its all-time high of 16.21%, reached on December 31, 2016.
Performance
ALRN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-74.08%
+10.80%+12.72%
September 30, 2024
Summary
- As of February 8, 2025, ALRN quarterly return on equity is -74.08%, with the most recent change of +10.80% (+12.72%) on September 30, 2024.
- Over the past year, ALRN quarterly ROE has increased by +16.91% (+18.58%).
- ALRN quarterly ROE is now -103.84% below its all-time high of 1928.67%, reached on December 31, 2017.
Performance
ALRN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALRN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.7% | +18.6% |
| 3 y3 years | -31.3% | +28.1% |
| 5 y5 years | -41.9% | +28.1% |
ALRN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -283.3% | at low | -49.8% | +46.9% |
| 5 y | 5-year | -283.3% | at low | -49.8% | +56.5% |
| alltime | all time | -1509.2% | at low | -103.8% | +84.1% |
Aileron Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -74.08%(-12.7%) |
| Jun 2024 | - | -84.88%(-11.2%) |
| Mar 2024 | - | -95.55%(-31.4%) |
| Dec 2023 | -228.43%(+55.7%) | -139.37%(+53.2%) |
| Sep 2023 | - | -90.99%(-11.0%) |
| Jun 2023 | - | -102.25%(-9.1%) |
| Mar 2023 | - | -112.51%(+9.1%) |
| Dec 2022 | -146.75%(+146.3%) | -103.08%(+14.4%) |
| Sep 2022 | - | -90.10%(+19.5%) |
| Jun 2022 | - | -75.39%(+27.1%) |
| Mar 2022 | - | -59.30%(+19.9%) |
| Dec 2021 | -59.59%(-65.7%) | -49.47%(-8.7%) |
| Sep 2021 | - | -54.19%(-15.1%) |
| Jun 2021 | - | -63.81%(-23.4%) |
| Mar 2021 | - | -83.29%(-49.8%) |
| Dec 2020 | -173.96% | -165.80%(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -170.37%(+6.5%) |
| Jun 2020 | - | -160.04%(+8.8%) |
| Mar 2020 | - | -147.06%(+2.3%) |
| Dec 2019 | -183.01%(+13.7%) | -143.80%(+5.1%) |
| Sep 2019 | - | -136.86%(+4.9%) |
| Jun 2019 | - | -130.47%(-4.4%) |
| Mar 2019 | - | -136.50%(+29.2%) |
| Dec 2018 | -160.95%(+240.3%) | -105.62%(+24.3%) |
| Sep 2018 | - | -84.99%(+23.6%) |
| Jun 2018 | - | -68.78%(-85.2%) |
| Mar 2018 | - | -465.94%(-124.2%) |
| Dec 2017 | -47.29%(-391.7%) | 1928.67%(+3825.6%) |
| Sep 2017 | - | 49.13%(+97.1%) |
| Jun 2017 | - | 24.93%(-35.2%) |
| Mar 2017 | - | 38.46%(+137.3%) |
| Dec 2016 | 16.21%(+18.8%) | 16.21% |
| Dec 2015 | 13.65% | - |
FAQ
- What is Aileron Therapeutics annual return on equity?
- What is the all time high annual ROE for Aileron Therapeutics?
- What is Aileron Therapeutics annual ROE year-on-year change?
- What is Aileron Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly ROE year-on-year change?
What is Aileron Therapeutics annual return on equity?
The current annual ROE of ALRN is -228.43%
What is the all time high annual ROE for Aileron Therapeutics?
Aileron Therapeutics all-time high annual return on equity is 16.21%
What is Aileron Therapeutics annual ROE year-on-year change?
Over the past year, ALRN annual return on equity has changed by -81.68% (-55.66%)
What is Aileron Therapeutics quarterly return on equity?
The current quarterly ROE of ALRN is -74.08%
What is the all time high quarterly ROE for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly return on equity is 1928.67%
What is Aileron Therapeutics quarterly ROE year-on-year change?
Over the past year, ALRN quarterly return on equity has changed by +16.91% (+18.58%)